Feedback / Questions
hydrogen sulfide-releasing derivative of ketoprofen (ATB-352) - Antibe
otenaproxesul (ATB-346) - Antibe
https://www.proactiveinvestors.com/companies/news/926029/antibe-therapeutics-engages-stern-ir-to-expand-its-investor-relations-program-and-broaden-visibility-within-us-capital-markets-926029.html
Aug 6, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next